Hot Topics
Neuropsychopharmacology (2009) 34, 244–246; doi:10.1038/npp.2008.157
Targeting nicotinic receptor antagonists as novel pharmacotherapies for tobacco dependence and relapse
Linda P Dwoskin1 and Michael T Bardo1
1University of Kentucky National Cooperative Drug Discovery Group, Lexington, KY, USA
Correspondence: Linda P Dwoskin, E-mail: ldwoskin@email.uky.edu
